Literature DB >> 21708936

Relationship between biomarkers of cigarette smoke exposure and biomarkers of inflammation, oxidative stress, and platelet activation in adult cigarette smokers.

Jianmin Liu1, Qiwei Liang, Kimberly Frost-Pineda, Raheema Muhammad-Kah, Lonnie Rimmer, Hans Roethig, Paul Mendes, Mohamadi Sarkar.   

Abstract

BACKGROUND: Cigarette smoking is a risk factor for several diseases, including cardiovascular disease, chronic obstructive pulmonary disease, and lung cancer, but the role of specific smoke constituents in these diseases has not been clearly established.
METHODS: The relationships between biomarkers of potential harm (BOPH), associated with inflammation [white blood cell (WBC), high sensitivity C-reactive protein (hs-CRP), fibrinogen, and von Willebrand factor (vWF)], oxidative stress [8-epi-prostaglandin F(2α) (8-epiPGF(2α))] and platelet activation [11-dehydro-thromboxin B(2) (11-dehTxB(2))], and machine-measured tar yields (grouped into four categories), biomarkers of exposure (BOE) to cigarette smoke: nicotine and its five metabolites (nicotine equivalents), 4-methylnitrosamino-1-(3-pyridyl)-1-butanol (total NNAL), carboxyhemoglobin, 1-hydroxypyrene, 3-hydroxypropylmercapturic acid, and monohydroxybutenyl-mercapturic acid, were investigated in 3,585 adult smokers and 1,077 nonsmokers.
RESULTS: Overall, adult smokers had higher levels of BOPHs than nonsmokers. Body mass index (BMI), smoking duration, tar category, and some of the BOEs were significant factors in the multiple regression models. Based on the F value, BMI was the highest ranking factor in the models for WBC, hs-CRP, fibrinogen, and 8-epiPGF(2α), respectively, and gender and smoking duration for 11-dehTxB(2) and vWF, respectively.
CONCLUSIONS: Although several demographic factors and some BOEs were statistically significant in the model, the R(2) values indicate that only up to 22% of the variability can be explained by these factors, reflecting the complexity and multifactorial nature of the disease mechanisms. IMPACT: The relationships between the BOEs and BOPHs observed in this study may help with the identification of appropriate biomarkers and improve the design of clinical studies in smokers. ©2011 AACR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21708936     DOI: 10.1158/1055-9965.EPI-10-0987

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  33 in total

1.  Interleukin-6 and body mass index, tobacco use, and sleep in gynecologic cancers.

Authors:  Elizabeth L Kacel; Janae L Kirsch; Timothy S Sannes; Seema Patidar; Rachel Postupack; Sally Jensen; Shan Wong; Stephanie Garey; Stacy Dodd; Chantel M Ulfig; Christina S McCrae; Michael E Robinson; Jacqueline Castagno; Gregory S Schultz; Deidre B Pereira
Journal:  Health Psychol       Date:  2019-08-01       Impact factor: 4.267

2.  Dietary antioxidant and anti-inflammatory intake modifies the effect of cadmium exposure on markers of systemic inflammation and oxidative stress.

Authors:  Justin A Colacino; Anna E Arthur; Kelly K Ferguson; Laura S Rozek
Journal:  Environ Res       Date:  2014-03-05       Impact factor: 6.498

3.  Cigarette smoking and variations in systemic immune and inflammation markers.

Authors:  Meredith S Shiels; Hormuzd A Katki; Neal D Freedman; Mark P Purdue; Nicolas Wentzensen; Britton Trabert; Cari M Kitahara; Michael Furr; Yan Li; Troy J Kemp; James J Goedert; Cindy M Chang; Eric A Engels; Neil E Caporaso; Ligia A Pinto; Allan Hildesheim; Anil K Chaturvedi
Journal:  J Natl Cancer Inst       Date:  2014-10-01       Impact factor: 13.506

4.  Prediagnostic levels of urinary 8-epi-prostaglandin F2α and prostaglandin E2 metabolite, biomarkers of oxidative damage and inflammation, and risk of hepatocellular carcinoma.

Authors:  Jian-Min Yuan; Menno Grouls; Steven G Carmella; Renwei Wang; Alisa Heskin; Yang Jiang; Yu-Ting Tan; Jennifer Adams-Haduch; Yu-Tang Gao; Stephen S Hecht
Journal:  Carcinogenesis       Date:  2019-08-22       Impact factor: 4.944

5.  Household air pollution: a call for studies into biomarkers of exposure and predictors of respiratory disease.

Authors:  Jamie Rylance; Stephen B Gordon; Luke P Naeher; Archana Patel; John R Balmes; Olorunfemi Adetona; Derek K Rogalsky; William J Martin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-03-01       Impact factor: 5.464

6.  1-Hydroxypyrene and oxidative stress marker levels among painting workers and office workers at shipyard.

Authors:  Younglim Kho; Eun-Hee Lee; Hong Jae Chae; Kyungho Choi; Domyung Paek; Sangshin Park
Journal:  Int Arch Occup Environ Health       Date:  2014-07-05       Impact factor: 3.015

Review 7.  The National Cancer Institute's PREVENT Cancer Preclinical Drug Development Program: overview, current projects, animal models, agent development strategies, and molecular targets.

Authors:  Robert H Shoemaker; Chen S Suen; Cathy A Holmes; Judith R Fay; Vernon E Steele
Journal:  Semin Oncol       Date:  2015-09-08       Impact factor: 4.929

8.  2-Phenethyl Isothiocyanate, Glutathione S-transferase M1 and T1 Polymorphisms, and Detoxification of Volatile Organic Carcinogens and Toxicants in Tobacco Smoke.

Authors:  Jian-Min Yuan; Sharon E Murphy; Irina Stepanov; Renwei Wang; Steven G Carmella; Heather H Nelson; Dorothy Hatsukami; Stephen S Hecht
Journal:  Cancer Prev Res (Phila)       Date:  2016-04-20

9.  Linkage analysis identifies a locus for plasma von Willebrand factor undetected by genome-wide association.

Authors:  Karl C Desch; Ayse B Ozel; David Siemieniak; Yossi Kalish; Jordan A Shavit; Courtney D Thornburg; Anjali A Sharathkumar; Caitlin P McHugh; Cathy C Laurie; Andrew Crenshaw; Daniel B Mirel; Yoonhee Kim; Cheryl D Cropp; Anne M Molloy; Peadar N Kirke; Joan E Bailey-Wilson; Alexander F Wilson; James L Mills; John M Scott; Lawrence C Brody; Jun Z Li; David Ginsburg
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-24       Impact factor: 11.205

10.  Applying Tobacco, Environmental, and Dietary-Related Biomarkers to Understand Cancer Etiology and Evaluate Prevention Strategies.

Authors:  Lisa A Peterson; Silvia Balbo; Naomi Fujioka; Dorothy K Hatsukami; Stephen S Hecht; Sharon E Murphy; Irina Stepanov; Natalia Y Tretyakova; Robert J Turesky; Peter W Villalta
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-02-12       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.